4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-17-061596
President & CEO returned 18,069 shares (to the company)
- President & CEO acquired 55,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
ROBIN HOWARD W · President & CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-11-15 | Grant or award : show line 1 in the form | +55,000 | 207,504 | D | ||
| 2017-11-16 | Returned to the company : show line 2 in the form | −18,069 | $44.23 | $799,192 | 189,435 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-11-15 | Grant or award : show line 3 in the form Stock Option | +137,500 | 137,500 | D |
Loading xslF345X03/doc4.xml…